NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	06/03/2020
Target sample size	578
Countries of recruitment	Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : doravirine/islatravir Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Bictegravir/Emtricitabine/Tenofovir Alafenamide Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety efficacy
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria